Lympro is going to garner more attention from the medical community with the passing of every month. BP is already aware of the data release yesterday and you may be sure are considering what part this new blood test is going to play in the R&D. Millions are being wasted because of poor patient selection which is now going to be possible to eliminate, and at the same time save millions for BP. I hope our Media wing is already with the plans to maximize exposure to Lympro's success.
I can distinctly remember Gerald mentioning during his most recent CC the possibility that AMBS would be willing to sell LYMPRO in the right situation. That struck me as strange, kind of "out of the blue" remark which we had not heard before. Given the stellar results of the LP-002 data, it makes you wonder if there may be negotiations going on in that regard. I personally hope not as it is an asset which is only going to become more valuable in the coming years, but who knows.......One thing is for sure, Gerald's credibility has been somewhat restored here. I think our next news will be regarding ICON and LYMPRO. Let the honeymoon begin!
Have a terrific weekend everyone, get some rest, and be safe.